跳至主要内容
临床试验/CTRI/2025/02/080085
CTRI/2025/02/080085尚未招募不适用

Comparative analysis between outcomes of 3 percentage polidocanol sclerotherapy versus Modified Barrons rubber band ligation in the management of grade 2 internal hemorrhoidal disease : A non inferiority randomised control trial

AIIMS Patna1 个研究点 分布在 1 个国家目标入组 332 人开始时间: 2026年2月9日

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
332
试验地点
1
主要终点
To assess the patient related outcomes blood loss pain prolapse itching soiling of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease using Patient Reported Outcome Measures Haemorrhoidal Impact and Satisfaction Score PROM HISS questionnaire

研究概览

简要总结

The study will be conducted in the Department of General Surgery AIIMS Patna and will include patients with Grade 2 Internal Hemorrhoidal Disease who have undergone at least one month of conservative management including dietary and lifestyle modifications along with medical management using Micronised Purified Flavonoid Fraction and have not experienced symptom relief Eligible patients will be randomized into two parallel groups Group A receiving 3 percentage Polidocanol Sclerotherapy and Group B undergoing Modified Barrons Rubber Band Ligation with an allocation ratio of 1 to 1 Patients who refuse randomization will be allowed to choose their preferred treatment modality The Sclerotherapy group will receive 4 ml of 3 percentage Polidocanol foam prepared using the Modified Tessari technique and injected via a Kelly proctoscope in the Jackknife position with a maximum dose of 20 ml per session treating multiple nodules if necessary The RBL group will undergo ligation in the Jackknife position using a Kelly proctoscope and a reusable metal ligation device with suction applying two rubber bands per hemorrhoidal pedicle if required Patient related outcomes will be assessed using the Patient Reported Outcome Measure Hemorrhoidal Impact and Satisfaction Score PROM HISS questionnaire which evaluates hemorrhoidal symptoms impact on daily activities and satisfaction with treatment Follow up visits will be conducted at 1 week 6 weeks and 3 months with potential retreatment at 6 weeks if necessary Data will be analyzed on both an intention to treat and per protocol basis with the total study duration expected to be between 1 to 1 year 6 months

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Age 18 years or older with grade 2 hemorrhoidal disease giving consent for participation Refractory to conservative management given for at least 1 month.

排除标准

  • Grade 1 3 and 4 hemorrhoidal disease Associated complications like strangulation or thrombosis Patients with external hemorrhoids Associated perianal fissure or fistula Patients who have undergone treatment for hemorrhoidal disease within last 12 months regardless of the type of treatment Patients with Inflammatory Bowel Disease Patients with coagulopathies arising from any cause or on anti-coagulation therapy Immunocompromised individuals Pregnant females.

结局指标

主要结局

To assess the patient related outcomes blood loss pain prolapse itching soiling of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease using Patient Reported Outcome Measures Haemorrhoidal Impact and Satisfaction Score PROM HISS questionnaire

时间窗: day 0 | 1 week | 6 weeks | 3 months

次要结局

  • To assess the complication rate of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease(6 weeks)
  • To assess the recurrence rate of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease where recurrence means subjective return of symptoms as told by patient(3 months)

研究者

发起方
AIIMS Patna
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Swarnima Shubhadarshini

all india institute of medical sciences patna

研究点 (1)

Loading locations...

相似试验